These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synthesis of novel heterocyclic ring-fused 18β-glycyrrhetinic acid derivatives with antitumor and antimetastatic activity. Gao C, Dai FJ, Cui HW, Peng SH, He Y, Wang X, Yi ZF, Qiu WW. Chem Biol Drug Des; 2014 Aug; 84(2):223-33. PubMed ID: 24612785 [Abstract] [Full Text] [Related]
9. N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity. Lallemand B, Chaix F, Bury M, Bruyère C, Ghostin J, Becker JP, Delporte C, Gelbcke M, Mathieu V, Dubois J, Prévost M, Jabin I, Kiss R. J Med Chem; 2011 Oct 13; 54(19):6501-13. PubMed ID: 21888390 [Abstract] [Full Text] [Related]
10. Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance. Jin L, Huang R, Huang X, Zhang B, Ji M, Wang H. Bioorg Med Chem; 2018 May 01; 26(8):1759-1775. PubMed ID: 29486954 [Abstract] [Full Text] [Related]
16. Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors. Scotti A, Trapella C, Ferretti V, Gallerani E, Gavioli R, Marastoni M. J Enzyme Inhib Med Chem; 2016 May 01; 31(3):456-63. PubMed ID: 25942361 [Abstract] [Full Text] [Related]
17. Design, Synthesis, and Biological Activity of Isosyringolin A. Kitahata S, Chiba T, Yoshida T, Ri M, Iida S, Matsuda A, Ichikawa S. Org Lett; 2016 May 06; 18(9):2312-5. PubMed ID: 27123978 [Abstract] [Full Text] [Related]